World Diabetes Day is just around the corner and to help highlight the ways pharma is helping to support patients, we spoke to industry experts who outlined some of their most recent research and therapeutic developments. You'll find these articles below as well as a contribution from Thermo Fisher Scientific's Laura Marozsan, who discusses the importance of connected technologies for boosting companies' digital capabilities, as well as the latest entry in our Pandemic Diaries series.

Until next time, Maryam Mahdi, Associate Editor.
 
DRUG DISCOVERY
Diabetes: Finding a Panacea
11/10/2020 | Maryam Mahdi
How can we effectively manage the treatment of type 1 diabetes?
TECHNOLOGY AND EQUIPMENT
Embracing the Digital Era
11/09/2020 | Laura Marozsan
From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies.
BUSINESS PRACTICE
The Pandemic Diaries
11/10/2020 | Erik Haeffler, Don O’Callaghan, Amélie Boulais
We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.
DRUG DISCOVERY
It’s Complicated
11/11/2020 | Maryam Mahdi
Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.
 
Webinar
Interested in AAV-based gene therapies?

Don’t miss our three-part educational webinar series with Cytiva that covers modern plasmid and AAV production for gene therapy applications. Find out more
 
White Papers
Benefits of Using Nanoparticle Tracking Analysis in Nanoscale Material Characterization

The production of nanoscale materials includes use and experimentation with a wide range of substances. Read more
Development of Nasal Spray Medications

Droplet size impacts how an active ingredient is deposited in the nasal cavity and therefore how well it is absorbed by the body. Read more
 
Product Profiles
Johnson Matthey’s advanced catalysts deliver better processes

Discover how JM’s world-class knowhow, together with our portfolio of catalyst technologies, biocatalysis capabilities, and screening services, helps to make chemistries more efficient, selective and sustainable. Read more​​​​​​​
OneXpress™ Solution for Accelerating Development to Commercialization

Catalent’s new OneXpress™ solution combines phase-appropriate scale and technologies with expertise across diverse dose forms to accelerate a program’s development to commercialization. Read more
iLAB: Intelligent Lean Lab (a product + process solution)

iLAB uses decision sciences and business analytics. The product is a virtual replica of a physical lab’s infrastructure and operation. It prescribes a lab design using business management principles. Read more
 
Special Promotions
Join the industry at E&L Europe Online!

Jam-packed with expert speakers and key industry personnel, this year's online event will provide you with everything you need to know about extractables and leachables; from regulations all the way through to carrying out E&L studies. Learn more
The Cell + Gene Curator - a newsletter focused on the science of cell and gene therapies

Connecting you to discoveries, innovation, and business updates from the cell and gene therapy community. Learn more and subscribe
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited

Texere Publishing Limited, Booths Park 1,
Chelford Road, Knutsford, WA16 8GS, UK
Registered Company Number: 08113419
Texere Publishing Inc., 115 Broadway, FL 5,
New York, NY 10006, USA
Federal Identification Number: 81-4613586